Oyster Point Pharma

40°40′43″N 78°14′35″W / 40.678631°N 78.243038°W / 40.678631; -78.243038

Oyster Point Pharma, Inc.
Company typeSubsidiary
Nasdaq: OYST
IndustryBiotechnology
Founded2015 (2015)
DefunctJanuary 2023 (2023-01)
FateAcquired
SuccessorViatris
Headquarters
Princeton, New Jersey
,
United States
Key people
Jeffrey Nau (president and CEO)
OwnerViatris
Websiteoysterpointrx.com

Oyster Point Pharma was an American biopharmaceutical company based in Princeton, New Jersey, focusing on the development of pharmaceutical therapies to treat ophthalmic diseases. It was acquired by Viatris in 2023.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.